Documente
Media
The SFJ Pharmaceuticals Group Announces Agreement With Pfizer to Co-develop Dacomitinib as First-Line Treatment for Patients With Advanced Non-small Cell Lung Cancer
Editură
sfj-pharmaceuticals
Publicații
(
1
)